LensX Lasers

About LensX Lasers

LensX Lasers, Inc. was a privately held medical device company that developed and manufactured femtosecond laser systems for ophthalmic surgery. The company was founded in 2008 by Dr. Ron Kurtz and Eric Weinberg. Dr. Kurtz, an ophthalmologist, had previously co-founded IntraLase Corp., where he was instrumental in developing femtosecond laser technology for LASIK procedures. Recognizing the potential to apply this precise cutting technology to cataract surgery, which represents a significantly larger market, he established LenSx.

The company's core product is the LenSx Laser System, a fully integrated, image-guided femtosecond laser platform designed specifically for refractive cataract surgery. This system automates several of the most critical and manually demanding steps of the procedure. It utilizes high-definition optical coherence tomography (OCT) for 3-D visualization and guidance, allowing the surgeon to create precise incisions in the cornea, perform a perfectly centered anterior capsulotomy (the opening of the lens capsule), and fragment the cataractous lens for easier removal. This level of computer-guided precision and reproducibility was a significant departure from traditional manual techniques, aiming to improve surgical predictability and visual outcomes for patients. The technology allows surgeons to tailor the procedure to each patient's unique eye anatomy.

LensX operated in the ophthalmic surgical device market, serving ophthalmologists and surgical centers. Its business model centered on the sale of the laser systems and associated procedure fees. The company achieved a major milestone by becoming the first to receive FDA clearance for its femtosecond laser for use in cataract surgery, with approvals for anterior capsulotomy in August 2009, corneal incisions in December 2009, and phacofragmentation in April 2010. Following successful clinical evaluations and its landmark FDA clearances, LenSx Lasers was acquired by the global eye care company Alcon in a deal announced in July 2010. The acquisition involved an initial payment of \$361.5 million in cash, with potential for up to \$744 million based on performance milestones, validating the strategic value of femtosecond laser technology in the cataract surgery market.